2019-2021 
Development & characterization of two monoclonal antibodies: Anti-EG-VEGF & anti-PROKR2
2018
EB18180 ALFAIDY/AF EG-VEGF is a new biomarker for preeclampsia
EB18179 ALFAIDY/AF Use of PROKR2 antagonists to treat preeclampsia
2017
PCT/EP2017/082321 Antagonist of Prokineticin receptor 2 for use as a medicament for treating an EG-VEGF-related cancer
2016
EP16306666 Protected technology: Method of obtaining an animal model of a cancer, animal model and uses thereof